Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Association of White Matter Hyperintensities and Cardiovascular Disease

Association of White Matter Hyperintensities and Cardiovascular Disease Cardiac and cerebrovascular diseases are currently the leading causes of mortality and disability worldwide. Both the heart and brain display similar vascular anatomy, with large conduit arteries running on the surface of the organ providing tissue perfusion through an intricate network of penetrating small vessels. Both organs rely on fine tuning of local blood flow to match metabolic demand. Blood flow regulation requires adequate functioning of the microcirculation in both organs, with loss of microvascular function, termed small vessel disease (SVD) underlying different potential clinical manifestations. SVD in the heart, known as coronary microvascular dysfunction, can cause chronic or acute myocardial ischemia and may lead to development of heart failure. In the brain, cerebral SVD can cause an acute stroke syndrome known as lacunar stroke or more subtle pathological alterations of the brain parenchyma, which may eventually lead to neurological deficits or cognitive decline in the long term. Coronary microcirculation cannot be visualized in vivo in humans, and functional information can be deduced by measuring the coronary flow reserve. The diagnosis of cerebral SVD is largely based on brain magnetic resonance imaging, with white matter hyperintensities, microbleeds, and brain atrophy reflecting key structural changes. There is evidence that such structural changes reflect underlying cerebral SVD. Here, we review interactions between SVD and cardiovascular risk factors, and we discuss the evidence linking cerebral SVD with large vessel atheroma, atrial fibrillation, heart failure, and heart valve disease. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Circulation: Cardiovascular Imaging Wolters Kluwer Health

Association of White Matter Hyperintensities and Cardiovascular Disease

Download PDF
13 pages

Loading next page...
 
/lp/wolters-kluwer-health/association-of-white-matter-hyperintensities-and-cardiovascular-1tiiNv8ifv

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
© 2020 American Heart Association, Inc.
ISSN
1941-9651
eISSN
1942-0080
DOI
10.1161/CIRCIMAGING.120.010460
Publisher site
See Article on Publisher Site

Abstract

Cardiac and cerebrovascular diseases are currently the leading causes of mortality and disability worldwide. Both the heart and brain display similar vascular anatomy, with large conduit arteries running on the surface of the organ providing tissue perfusion through an intricate network of penetrating small vessels. Both organs rely on fine tuning of local blood flow to match metabolic demand. Blood flow regulation requires adequate functioning of the microcirculation in both organs, with loss of microvascular function, termed small vessel disease (SVD) underlying different potential clinical manifestations. SVD in the heart, known as coronary microvascular dysfunction, can cause chronic or acute myocardial ischemia and may lead to development of heart failure. In the brain, cerebral SVD can cause an acute stroke syndrome known as lacunar stroke or more subtle pathological alterations of the brain parenchyma, which may eventually lead to neurological deficits or cognitive decline in the long term. Coronary microcirculation cannot be visualized in vivo in humans, and functional information can be deduced by measuring the coronary flow reserve. The diagnosis of cerebral SVD is largely based on brain magnetic resonance imaging, with white matter hyperintensities, microbleeds, and brain atrophy reflecting key structural changes. There is evidence that such structural changes reflect underlying cerebral SVD. Here, we review interactions between SVD and cardiovascular risk factors, and we discuss the evidence linking cerebral SVD with large vessel atheroma, atrial fibrillation, heart failure, and heart valve disease.

Journal

Circulation: Cardiovascular Imaging – Wolters Kluwer Health

Published: Aug 1, 2020

References

  • Heart disease and stroke statistics-2020 update: a report from the american heart association.
    Virani, SS; Alonso, A; Benjamin, EJ; Bittencourt, MS; Callaway, CW; Carson, AP; Chamberlain, AM; Chang, AR; Cheng, S; Delling, FN
  • The global burden of disease study and the preventable burden of NCD.
    Benziger, CP; Roth, GA; Moran, AE
  • Small-vessel disease in the heart and brain: current knowledge, unmet therapeutic need, and future directions.
    Berry, C; Sidik, N; Pereira, AC; Ford, TJ; Touyz, RM; Kaski, JC; Hainsworth, AH
  • Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Hay, SI; Abajobir, AA; Abate, KH; Abbafati, C; Abbas, KM; Abd-Allah, F; Abdulkader, RS; Abdulle, AM; Abebo, TA; Abera, SF
  • Reappraisal of ischemic heart disease.
    Kaski, JC; Crea, F; Gersh, BJ; Camici, PG
  • Coronary microvascular dysfunction in hypertrophy and heart failure.
    Camici, PG; Tschöpe, C; Di Carli, MF; Rimoldi, O; Van Linthout, S
  • Brain health and shared risk factors for dementia and stroke.
    Gardener, H; Wright, CB; Rundek, T; Sacco, RL
  • Cardiovascular disease and brain health: focus on white matter hyperintensities.
    Moroni, F; Ammirati, E; Rocca, MA; Filippi, M; Magnoni, M; Camici, PG
  • Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.
    Wardlaw, JM; Smith, EE; Biessels, GJ; Cordonnier, C; Fazekas, F; Frayne, R; Lindley, RI; O’Brien, JT; Barkhof, F; Benavente, OR
  • White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities.
    Alber, J; Alladi, S; Bae, HJ; Barton, DA; Beckett, LA; Bell, JM; Berman, SE; Biessels, GJ; Black, SE; Bos, I
  • Coronary microvascular dysfunction.
    Camici, PG; Crea, F
  • The clinical value of myocardial blood flow measurement.
    Camici, PG; Rimoldi, OE
  • Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders.
    Zlokovic, BV
  • Coronary microvascular dysfunction: mechanisms and functional assessment.
    Camici, PG; d’Amati, G; Rimoldi, O
  • The coronary circulation and blood flow in left ventricular hypertrophy.
    Camici, PG; Olivotto, I; Rimoldi, OE
  • Nonobstructive coronary artery disease and risk of myocardial infarction.
    Maddox, TM; Stanislawski, MA; Grunwald, GK; Bradley, SM; Ho, PM; Tsai, TT; Patel, MR; Sandhu, A; Valle, J; Magid, DJ
  • Regulation of cerebral vasculature in normal and ischemic brain.
    Kulik, T; Kusano, Y; Aronhime, S; Sandler, AL; Winn, HR
  • Integrative regulation of human brain blood flow.
    Willie, CK; Tzeng, YC; Fisher, JA; Ainslie, PN
  • Neurovascular regulation in the ischemic brain.
    Jackman, K; Iadecola, C
  • Functional morphology of the blood-brain barrier in health and disease.
    Liebner, S; Dijkhuizen, RM; Reiss, Y; Plate, KH; Agalliu, D; Constantin, G
  • Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.
    Pantoni, L
  • Microcirculatory dysfunction in the heart and the brain.
    Mejía-Rentería, H; Matias-Guiu, JA; Lauri, F; Yus, M; Escaned, J
  • Cerebral and extracerebral vasoreactivity in patients with different clinical manifestations of cerebral small-vessel disease: data from the significance of hemodynamic and hemostatic factors in the course of different manifestations of cerebral small-vessel disease study.
    Staszewski, J; Skrobowska, E; Piusińska-Macoch, R; Brodacki, B; Stępień, A
  • What are white matter hyperintensities made of? Relevance to vascular cognitive impairment.
    Wardlaw, JM; Valdés Hernández, MC; Muñoz-Maniega, S
  • White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home.
    Ylikoski, A; Erkinjuntti, T; Raininko, R; Sarna, S; Sulkava, R; Tilvis, R
  • Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study.
    Garde, E; Mortensen, EL; Krabbe, K; Rostrup, E; Larsson, HB
  • Cerebral small vessel disease and renal function: systematic review and meta-analysis.
    Makin, SDJ; Cook, FAB; Dennis, MS; Wardlaw, JM
  • Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment.
    Black, S; Gao, F; Bilbao, J
  • Pathologic correlates of incidental MRI white matter signal hyperintensities.
    Fazekas, F; Kleinert, R; Offenbacher, H; Schmidt, R; Kleinert, G; Payer, F; Radner, H; Lechner, H
  • Pathologic correlates of increased signals of the centrum ovale on magnetic resonance imaging.
    Munoz, DG; Hastak, SM; Harper, B; Lee, D; Hachinski, VC
  • Pathogenesis of white matter changes in cerebral small vessel diseases: beyond vessel-intrinsic mechanisms.
    Joutel, A; Chabriat, H
  • Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: a pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort.
    Smallwood, A; Oulhaj, A; Joachim, C; Christie, S; Sloan, C; Smith, AD; Esiri, M
  • In Vivo imaging of venous side cerebral small-vessel disease in older adults: an MRI method at 7T.
    Shaaban, CE; Aizenstein, HJ; Jorgensen, DR; MacCloud, RL; Meckes, NA; Erickson, KI; Glynn, NW; Mettenburg, J; Guralnik, J; Newman, AB
  • Blood-brain barrier: ageing and microvascular disease–systematic review and meta-analysis.
    Farrall, AJ; Wardlaw, JM
  • Neuropathology of white matter lesions, blood-brain barrier dysfunction, and dementia.
    Hainsworth, AH; Minett, T; Andoh, J; Forster, G; Bhide, I; Barrick, TR; Elderfield, K; Jeevahan, J; Markus, HS; Bridges, LR
  • Quantification of afferent vessels shows reduced brain vascular density in subjects with leukoaraiosis.
    Moody, DM; Thore, CR; Anstrom, JA; Challa, VR; Langefeld, CD; Brown, WR
  • Venous collagenosis and arteriolar tortuosity in leukoaraiosis.
    Brown, WR; Moody, DM; Challa, VR; Thore, CR; Anstrom, JA
  • Age-associated white matter lesions: the MRC Cognitive Function and Ageing Study.
    Wharton, SB; Simpson, JE; Brayne, C; Ince, PG
  • Blood-brain barrier impairment and hypoperfusion are linked in cerebral small vessel disease.
    Wong, SM; Jansen, JFA; Zhang, CE; Hoff, EI; Staals, J; van Oostenbrugge, RJ; Backes, WH
  • Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI.
    Verhaaren, BF; Debette, S; Bis, JC; Smith, JA; Ikram, MK; Adams, HH; Beecham, AH; Rajan, KB; Lopez, LM; Barral, S
  • The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis.
    Debette, S; Markus, HS
  • The correlation between white matter hyperintensity and balance disorder and fall risk: An observational, prospective cohort study.
    Shen, DC; Wu, SL; Shi, YZ; Wang, S; Zhang, YM; Wang, CX
  • Progression of white matter hyperintensities of presumed vascular origin increases the risk of falls in older people.
    Callisaya, ML; Beare, R; Phan, T; Blizzard, L; Thrift, AG; Chen, J; Srikanth, VK
  • The relationship between cerebral white matter hyperintensities and lower urinary tract function in a population based, geriatric cohort.
    Wehrberger, C; Jungwirth, S; Fischer, P; Tragl, KH; Krampla, W; Marlies, W; Madersbacher, S
  • WMH and long-term outcomes in ischemic stroke: a systematic review and meta-analysis.
    Georgakis, MK; Duering, M; Wardlaw, JM; Dichgans, M
  • White matter hyperintensities in late life depression: a systematic review.
    Herrmann, LL; Le Masurier, M; Ebmeier, KP
  • Depression related cerebral pathology and its relationship with cognitive functioning: A systematic review.
    Jamieson, A; Goodwill, AM; Termine, M; Campbell, S; Szoeke, C
  • White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study.
    Verdelho, A; Madureira, S; Moleiro, C; Ferro, JM; Santos, CO; Erkinjuntti, T; Pantoni, L; Fazekas, F; Visser, M; Waldemar, G
  • Impact of multiple pathologies on the threshold for clinically overt dementia.
    Kapasi, A; DeCarli, C; Schneider, JA
  • Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer’s disease.
    Esiri, MM; Nagy, Z; Smith, MZ; Barnetson, L; Smith, AD
  • White matter hyperintensities are a core feature of Alzheimer’s disease: Evidence from the dominantly inherited Alzheimer network.
    Lee, S; Viqar, F; Zimmerman, ME; Narkhede, A; Tosto, G; Benzinger, TL; Marcus, DS; Fagan, AM; Goate, A; Fox, NC
  • Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline.
    Debette, S; Seshadri, S; Beiser, A; Au, R; Himali, JJ; Palumbo, C; Wolf, PA; DeCarli, C
  • Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.
    Jeerakathil, T; Wolf, PA; Beiser, A; Massaro, J; Seshadri, S; D’Agostino, RB; DeCarli, C
  • Atrial fibrillation is associated with anterior predominant white matter lesions in patients presenting with embolic stroke.
    Mayasi, Y; Helenius, J; McManus, DD; Goddeau, RP; Jun-O’Connell, AH; Moonis, M; Henninger, N
  • Brain magnetic resonance imaging abnormalities in patients with heart failure.
    Vogels, RL; van der Flier, WM; van Harten, B; Gouw, AA; Scheltens, P; Schroeder-Tanka, JM; Weinstein, HC
  • Cerebral perfusion is associated with white matter hyperintensities in older adults with heart failure.
    Alosco, ML; Brickman, AM; Spitznagel, MB; Garcia, SL; Narkhede, A; Griffith, EY; Raz, N; Cohen, R; Sweet, LH; Colbert, LH
  • Association of cardiac hemodynamic factors with severity of white matter hyperintensities in chronic valvular heart disease.
    Lee, WJ; Jung, KH; Ryu, YJ; Kim, JM; Lee, ST; Chu, K; Kim, M; Lee, SK; Roh, JK
  • Cerebral lesions on magnetic resonance imaging correlate with preoperative neurological status in neonates undergoing cardiopulmonary bypass surgery.
    Bertholdt, S; Latal, B; Liamlahi, R; Prêtre, R; Scheer, I; Goetti, R; Dave, H; Bernet, V; Schmitz, A; von Rhein, M
  • High prevalence of cerebral small vessel disease on 7T magnetic resonance imaging in familial hypercholesterolemia.
    Todate, Y; Uwano, I; Yashiro, S; Chida, A; Hasegawa, Y; Oda, T; Nagasawa, K; Honma, H; Sasaki, M; Ishigaki, Y
  • Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension: a randomized, double-blind and placebo-controlled clinical trial.
    Zhang, H; Cui, Y; Zhao, Y; Dong, Y; Duan, D; Wang, J; Sheng, L; Ji, T; Zhou, T; Hu, W
  • Glucose indices are associated with cognitive and structural brain measures in young adults.
    Weinstein, G; Maillard, P; Himali, JJ; Beiser, AS; Au, R; Wolf, PA; Seshadri, S; DeCarli, C
  • Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics.
    de Havenon, A; Majersik, JJ; Tirschwell, DL; McNally, JS; Stoddard, G; Rost, NS
  • Smoking and white matter hyperintensity progression: the ARIC-MRI Study.
    Power, MC; Deal, JA; Sharrett, AR; Jack, CR; Knopman, D; Mosley, TH; Gottesman, RF
  • Carotid atherosclerosis, silent ischemic brain damage and brain atrophy: a systematic review and meta-analysis.
    Moroni, F; Ammirati, E; Magnoni, M; D’Ascenzo, F; Anselmino, M; Anzalone, N; Rocca, MA; Falini, A; Filippi, M; Camici, PG
  • Progression of brain white matter hyperintensities in asymptomatic patients with carotid atherosclerotic plaques and no indication for revascularization.
    Ammirati, E; Moroni, F; Magnoni, M; Rocca, MA; Anzalone, N; Cacciaguerra, L; Di Terlizzi, S; Villa, C; Sizzano, F; Palini, A
  • Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function.
    Gaita, F; Corsinovi, L; Anselmino, M; Raimondo, C; Pianelli, M; Toso, E; Bergamasco, L; Boffano, C; Valentini, MC; Cesarani, F
  • The blunting of coronary flow reserve in hypertension with left ventricular hypertrophy is transmural and correlates with systolic blood pressure.
    Rimoldi, O; Rosen, SD; Camici, PG
  • Evaluation of coronary blood flow reserve by 13N-NH3 positron emission computed tomography (PET) with dipyridamole in the treatment of hypertension with the ACE inhibitor (Cilazapril).
    Masuda, D; Nohara, R; Tamaki, N; Hosokawa, R; Inada, H; Hikai, T; Chen, LG; Tadamura, E; Kudou, T; Konishi, J
  • Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia.
    Kaufmann, PA; Gnecchi-Ruscone, T; Schäfers, KP; Lüscher, TF; Camici, PG
  • Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus.
    Yokoyama, I; Momomura, S; Ohtake, T; Yonekura, K; Nishikawa, J; Sasaki, Y; Omata, M
  • Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function.
    Kaufmann, PA; Gnecchi-Ruscone, T; di Terlizzi, M; Schäfers, KP; Lüscher, TF; Camici, PG
  • Carotid intima-media thickness in patients with cardiac syndrome X and its association with high circulating levels of asymmetric dimethylarginine.
    Sen, N; Poyraz, F; Tavil, Y; Yazici, HU; Turfan, M; Hizal, F; Topal, S; Erdamar, H; Cakir, E; Yalçin, R
  • Myocardial perfusion is impaired and relates to cardiac dysfunction in patients with atrial fibrillation both before and after successful catheter ablation.
    Wijesurendra, RS; Liu, A; Notaristefano, F; Ntusi, NAB; Karamitsos, TD; Bashir, Y; Ginks, M; Rajappan, K; Betts, TR; Jerosch-Herold, M
  • Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond.
    Lloyd-Jones, DM; Hong, Y; Labarthe, D; Mozaffarian, D; Appel, LJ; Van Horn, L; Greenlund, K; Daniels, S; Nichol, G; Tomaselli, GF
  • Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects.
    Wiseman, RM; Saxby, BK; Burton, EJ; Barber, R; Ford, GA; O’Brien, JT
  • Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: two different patterns of myocardial perfusion associated with degree of hypertrophy.
    Gimelli, A; Schneider-Eicke, J; Neglia, D; Sambuceti, G; Giorgetti, A; Bigalli, G; Parodi, G; Pedrinelli, R; Parodi, O
  • Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke.
    Jimenez-Conde, J; Biffi, A; Rahman, R; Kanakis, A; Butler, C; Sonni, S; Massasa, E; Cloonan, L; Gilson, A; Capozzo, K
  • Incidence and risk factors of leukoaraiosis from 4683 hospitalized patients: a cross-sectional study.
    Lin, Q; Huang, WQ; Ma, QL; Lu, CX; Tong, SJ; Ye, JH; Lin, HN; Gu, L; Yi, KH; Cai, LL
  • Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis.
    Yokoyama, I; Ohtake, T; Momomura, S; Nishikawa, J; Sasaki, Y; Omata, M
  • Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis.
    Baller, D; Notohamiprodjo, G; Gleichmann, U; Holzinger, J; Weise, R; Lehmann, J
  • Metabolic syndrome, prediabetes, and brain abnormalities on mri in patients with manifest arterial disease: the SMART-MR study.
    Tiehuis, AM; van der Graaf, Y; Mali, WP; Vincken, K; Muller, M; Geerlings, MI
  • Obesity, insulin resistance, and incident small vessel disease on magnetic resonance imaging: atherosclerosis risk in communities study.
    Dearborn, JL; Schneider, AL; Sharrett, AR; Mosley, TH; Bezerra, DC; Knopman, DS; Selvin, E; Jack, CR; Coker, LH; Alonso, A
  • Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E.
    Title, LM; Cummings, PM; Giddens, K; Nassar, BA
  • Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes.
    Di Carli, MF; Janisse, J; Grunberger, G; Ager, J
  • Inhibition of DPP-4 by alogliptin improves coronary flow reserve and left ventricular systolic function evaluated by phase contrast cine magnetic resonance imaging in patients with type 2 diabetes and coronary artery disease.
    Kato, S; Fukui, K; Kirigaya, H; Gyotoku, D; Iinuma, N; Kusakawa, Y; Iguchi, K; Nakachi, T; Iwasawa, T; Kimura, K
  • Effects of sitagliptin on the coronary flow reserve, circulating endothelial progenitor cells and stromal cell-derived factor-1alpha.
    Morishita, T; Uzui, H; Ikeda, H; Amaya, N; Kaseno, K; Ishida, K; Fukuoka, Y; Tada, H
  • Acute effects of smoking light cigarettes on coronary microvascular functions.
    Ciftci, O; Caliskan, M; Gullu, H; Erdogan, D; Topcu, S; Guler, O; Yildirir, A; Muderrisoglu, H
  • Prevalence and risk factors of carotid plaque among middle-aged and elderly adults in Rural Tianjin, China.
    Zhan, C; Shi, M; Yang, Y; Pang, H; Fei, S; Bai, L; Liu, B; Tu, J; Huo, Y; Ning, X
  • Ischemic stroke subtypes: a population-based study of incidence and risk factors.
    Petty, GW; Brown, RD; Whisnant, JP; Sicks, JD; O’Fallon, WM; Wiebers, DO
  • Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study.
    Markus, HS; King, A; Shipley, M; Topakian, R; Cullinane, M; Reihill, S; Bornstein, NM; Schaafsma, A
  • Detection of intraplaque hemorrhage by magnetic resonance imaging in symptomatic patients with mild to moderate carotid stenosis predicts recurrent neurological events.
    Altaf, N; Daniels, L; Morgan, PS; Auer, D; MacSweeney, ST; Moody, AR; Gladman, JR
  • Carotid artery intima-media thickness, but not coronary artery calcium, predicts coronary vascular resistance in patients evaluated for coronary artery disease.
    Danad, I; Raijmakers, PG; Kamali, P; Harms, HJ; de Haan, S; Lubberink, M; van Kuijk, C; Hoekstra, OS; Lammertsma, AA; Smulders, YM
  • Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
    Go, AS; Hylek, EM; Phillips, KA; Chang, Y; Henault, LE; Selby, JV; Singer, DE
  • A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study.
    Wang, TJ; Massaro, JM; Levy, D; Vasan, RS; Wolf, PA; D’Agostino, RB; Larson, MG; Kannel, WB; Benjamin, EJ
  • Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis.
    Kwok, CS; Loke, YK; Hale, R; Potter, JF; Myint, PK
  • Silent cerebral infarcts and cerebral white matter lesions in patients with nonvalvular atrial fibrillation.
    Kobayashi, A; Iguchi, M; Shimizu, S; Uchiyama, S
  • Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from the ENGAGE AF-TIMI 48 Trial (effective anticoagulation with factor Xa next generation in atrial fibrillation-thrombolysis in myocardial infarction 48).
    Link, MS; Giugliano, RP; Ruff, CT; Scirica, BM; Huikuri, H; Oto, A; Crompton, AE; Murphy, SA; Lanz, H; Mercuri, MF
  • Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation.
    Range, FT; Schäfers, M; Acil, T; Schäfers, KP; Kies, P; Paul, M; Hermann, S; Brisse, B; Breithardt, G; Schober, O
  • Coronary microvascular dysfunction in heart failure with preserved ejection fraction - adding new pieces to the jigsaw puzzle.
    Van Linthout, S; Rimoldi, O; Tschöpe, C; Camici, PG
  • Brain metabolite alterations in Eisenmenger syndrome: evaluation with MR proton spectroscopy.
    Dokumaci, DŞ; Doğan, F; Yildirim, A; Boyaci, FN; Bozdoğan, E; Koca, B
  • Microcirculatory changes in children undergoing cardiac surgery: a prospective observational study.
    Scolletta, S; Marianello, D; Isgrò, G; Dapoto, A; Terranova, V; Franchi, F; Baryshnikova, E; Carlucci, C; Ranucci, M
  • Association of cardiovascular risk factors with MRI indices of cerebrovascular structure and function and white matter hyperintensities in young adults.
    Williamson, W; Lewandowski, AJ; Forkert, ND; Griffanti, L; Okell, TW; Betts, J; Boardman, H; Siepmann, T; McKean, D; Huckstep, O
  • Treatment of coronary microvascular dysfunction.
    Bairey Merz, CN; Pepine, CJ; Shimokawa, H; Berry, C
  • Cilostazol reduces blood brain barrier dysfunction, white matter lesion formation and motor deficits following chronic cerebral hypoperfusion.
    Edrissi, H; Schock, SC; Cadonic, R; Hakim, AM; Thompson, CS